Adalimumab treatment for chronic recurrent Vogt-Koyanagi-Harada disease with sunset glow fundus: A multicenter study.

Masaru Takeuchi,Shunsaku Nakai,Yoshihiko Usui,Kenichi Namba,Kayo Suzuki,Yosuke Harada,Sentaro Kusuhara,Toshikatsu Kaburaki,Rie Tanaka,Masaki Takeuchi,Nobuhisa Mizuki,Kei Nakai,Hiroshi Goto,Carl P Herbort

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society（2022）

引用 1|浏览2

暂无评分

摘要

ADA was shown to be effective in achieving remission of chronic recurrent VKH disease with SGF refractory to conventional treatments, and was generally well tolerated with few serious adverse events.

查看译文

关键词

Adalimumab,TNF inhibitors,chronic recurrent Vogt-Koyanagi-Harada disease,noninfectious uveitis,sunset glow fundus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要